首页 > 最新文献

中华心血管病杂志最新文献

英文 中文
[To give full attention to the medical enquiry]. [充分关注医疗调查]。
Q3 Medicine Pub Date : 2024-02-24 DOI: 10.3760/cma.j.cn112148-20231225-00530
D Y Hu
{"title":"[To give full attention to the medical enquiry].","authors":"D Y Hu","doi":"10.3760/cma.j.cn112148-20231225-00530","DOIUrl":"10.3760/cma.j.cn112148-20231225-00530","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 2","pages":"115-116"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139703634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Working together for scientific solutions to the obesity challenge]. [齐心协力,科学应对肥胖挑战]。
Q3 Medicine Pub Date : 2024-01-24 DOI: 10.3760/cma.j.cn112148-20231201-00478
D Liu, C P Li, W H Zhao
{"title":"[Working together for scientific solutions to the obesity challenge].","authors":"D Liu, C P Li, W H Zhao","doi":"10.3760/cma.j.cn112148-20231201-00478","DOIUrl":"10.3760/cma.j.cn112148-20231201-00478","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 1","pages":"3-6"},"PeriodicalIF":0.0,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139467055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Echocardiographic two-dimensional strain evaluation of right ventricular function in healthy adults]. [健康成年人右心室功能的超声心动图二维应变评估]。
Q3 Medicine Pub Date : 2024-01-24 DOI: 10.3760/cma.j.cn112148-20231019-00348
Y Li, Y Guo, C X Xia, X Y Meng, X Wang, T Xu, Y Zhong, F Wang

Objective: To explore the feasibility of using two-dimensional speckle tracking echocardiography for measuring right ventricular strain and function in healthy adults, and to analyze the impact of age and gender. Methods: This study is a cross-sectional study. Healthy adults who underwent physical examination in the Physical Examination Center of Beijing Hospital from January 1, 2020 to January 1, 2021 were included. Two researchers independently measured various right ventricular longitudinal strain indices using the Echopac software, including (global longitudinal strain (GLS), apical longitudinal strain (ALS), midventricle longitudinal strain (MLS), basal longitudinal strain (BLS), free wall GLS (FWGLS), free wall ALS (FWALS), free wall MLS (FWMLS) and free wall BLS (FWBLS)) as well as tricuspid annular plane systolic excursion (TAPSE) and right ventricle-fraction of area change (RVFAC). The above indicators were taken as the average of two physicians. The consistency of the measurements by two physicians was evaluated by the within-group correlation coefficient (ICC). Results: A total of 233 subjects were included, including 137 males, aged (58.5±14.2) years. ICC values was all above 0.8 with excellent agreement. The values of FWGLS and GLS in healthy adults were -26.63% and -21.89%, respectively. There was no statistically significant difference in TAPSE ((2.06±0.41)cm vs. (2.10±0.39)cm, P=0.510) and RVFAC ((51.17±9.91)% vs. (50.89±8.65)%, P=0.826) between males and females. The values of various right ventricular long axis strain indicators (GLS, ALS, MLS, BLS, FWGLS, FWMLS, FWMLS, FWBLS) in females aged 18 to 40 and 41 to 65 years were higher than those in males of the same age (all P<0.05), while there was no statistically significant difference in the values of various right ventricular long axis strain indicators between the sexes in subjects aged 65 years and above (all P>0.05). In females, the right ventricular GLS, ALS, MLS, FWGLS, FWALS, FWMLS, and FWBLS values in the groups aged 18 to 40 and 41 to 65 years were significantly higher than those in the group aged 65 years and above (all P<0.05). In contrast, no significant differences were found in these indices among different age groups in males (all P>0.05). Conclusions: Using two-dimensional speckle tracking technology in echocardiography to measure right ventricular strain indicators is feasible and highly reproducible. Gender and age have an impact on right ventricular strain indicators.

目的探讨使用二维斑点追踪超声心动图测量健康成年人右心室应变和功能的可行性,并分析年龄和性别的影响。研究方法本研究为横断面研究。纳入 2020 年 1 月 1 日至 2021 年 1 月 1 日在北京医院体检中心进行体检的健康成年人。两名研究人员使用 Echopac 软件独立测量了各种右心室纵向应变指数,包括(整体纵向应变(GLS)、心尖纵向应变(ALS)、心室中段纵向应变(MLS)、基底纵向应变(BLS)、游离壁 GLS(FWGLS)、游离壁 ALS(FWALS)、游离壁 MLS(FWMLS)和游离壁 BLS(FWBLS))以及三尖瓣环平面收缩期偏移(TAPSE)和右心室面积变化(RVFAC)。上述指标取两位医生的平均值。两名医生测量结果的一致性通过组内相关系数(ICC)进行评估。结果:共纳入 233 名受试者,其中男性 137 名,年龄(58.5±14.2)岁。ICC 值均在 0.8 以上,一致性极佳。健康成人的 FWGLS 和 GLS 值分别为 -26.63% 和 -21.89%。男性和女性的TAPSE((2.06±0.41)cm vs. (2.10±0.39)cm, P=0.510)和RVFAC((51.17±9.91)% vs. (50.89±8.65)%, P=0.826)差异无统计学意义。18-40岁和41-65岁女性的各种右心室长轴应变指标值(GLS、ALS、MLS、BLS、FWGLS、FWMLS、FWMLS、FWBLS)均高于同龄男性(PP均>0.05)。在女性中,18 至 40 岁组和 41 至 65 岁组的右心室 GLS、ALS、MLS、FWGLS、FWALS、FWMLS 和 FWBLS 值显著高于 65 岁及以上组(所有 PP 均大于 0.05)。结论在超声心动图中使用二维斑点追踪技术测量右心室应变指标是可行的,并且具有高度的可重复性。性别和年龄对右心室应变指标有影响。
{"title":"[Echocardiographic two-dimensional strain evaluation of right ventricular function in healthy adults].","authors":"Y Li, Y Guo, C X Xia, X Y Meng, X Wang, T Xu, Y Zhong, F Wang","doi":"10.3760/cma.j.cn112148-20231019-00348","DOIUrl":"10.3760/cma.j.cn112148-20231019-00348","url":null,"abstract":"<p><p><b>Objective:</b> To explore the feasibility of using two-dimensional speckle tracking echocardiography for measuring right ventricular strain and function in healthy adults, and to analyze the impact of age and gender. <b>Methods:</b> This study is a cross-sectional study. Healthy adults who underwent physical examination in the Physical Examination Center of Beijing Hospital from January 1, 2020 to January 1, 2021 were included. Two researchers independently measured various right ventricular longitudinal strain indices using the Echopac software, including (global longitudinal strain (GLS), apical longitudinal strain (ALS), midventricle longitudinal strain (MLS), basal longitudinal strain (BLS), free wall GLS (FWGLS), free wall ALS (FWALS), free wall MLS (FWMLS) and free wall BLS (FWBLS)) as well as tricuspid annular plane systolic excursion (TAPSE) and right ventricle-fraction of area change (RVFAC). The above indicators were taken as the average of two physicians. The consistency of the measurements by two physicians was evaluated by the within-group correlation coefficient (<i>ICC</i>). <b>Results:</b> A total of 233 subjects were included, including 137 males, aged (58.5±14.2) years. <i>ICC</i> values was all above 0.8 with excellent agreement. The values of FWGLS and GLS in healthy adults were -26.63% and -21.89%, respectively. There was no statistically significant difference in TAPSE ((2.06±0.41)cm vs. (2.10±0.39)cm, <i>P</i>=0.510) and RVFAC ((51.17±9.91)% vs. (50.89±8.65)%, <i>P</i>=0.826) between males and females. The values of various right ventricular long axis strain indicators (GLS, ALS, MLS, BLS, FWGLS, FWMLS, FWMLS, FWBLS) in females aged 18 to 40 and 41 to 65 years were higher than those in males of the same age (all <i>P</i><0.05), while there was no statistically significant difference in the values of various right ventricular long axis strain indicators between the sexes in subjects aged 65 years and above (all <i>P</i>>0.05). In females, the right ventricular GLS, ALS, MLS, FWGLS, FWALS, FWMLS, and FWBLS values in the groups aged 18 to 40 and 41 to 65 years were significantly higher than those in the group aged 65 years and above (all <i>P</i><0.05). In contrast, no significant differences were found in these indices among different age groups in males (all <i>P</i>>0.05). <b>Conclusions:</b> Using two-dimensional speckle tracking technology in echocardiography to measure right ventricular strain indicators is feasible and highly reproducible. Gender and age have an impact on right ventricular strain indicators.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 1","pages":"58-63"},"PeriodicalIF":0.0,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139466962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Review on heart failure and cardiomyopathy: dedicated to the 50th anniversary of Chinese Journal of Cardiology]. [心力衰竭与心肌病综述:献给《中华心脏病学杂志》创刊 50 周年】。]
Q3 Medicine Pub Date : 2023-12-24 DOI: 10.3760/cma.j.cn112148-20231024-00379
J Zhang
{"title":"[Review on heart failure and cardiomyopathy: dedicated to the 50th anniversary of Chinese Journal of Cardiology].","authors":"J Zhang","doi":"10.3760/cma.j.cn112148-20231024-00379","DOIUrl":"10.3760/cma.j.cn112148-20231024-00379","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 12","pages":"1219-1227"},"PeriodicalIF":0.0,"publicationDate":"2023-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138832067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Progress of hypertension management in China: 50 years overview]. [中国高血压管理进展:50 年综述]。
Q3 Medicine Pub Date : 2023-12-24 DOI: 10.3760/cma.j.cn112148-20231017-00336
Y M Li, N Yang
{"title":"[Progress of hypertension management in China: 50 years overview].","authors":"Y M Li, N Yang","doi":"10.3760/cma.j.cn112148-20231017-00336","DOIUrl":"10.3760/cma.j.cn112148-20231017-00336","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 12","pages":"1212-1218"},"PeriodicalIF":0.0,"publicationDate":"2023-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138832062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Interpretation of the 2023 European Society of Cardiology (ESC) Guidelines for the management of cardiomyopathies]. [对2023年欧洲心脏病学会(ESC)心肌病管理指南的解读]。
Q3 Medicine Pub Date : 2023-11-24 DOI: 10.3760/cma.j.cn112148-20230906-00131
X H Zheng, M Jiang, X L Li
随着近年来心肌病的相关循证医学证据及临床实践经验不断积累,欧洲心脏病学会于2023年公布了心肌病指南的更新,该指南结合整理了近年来领域内的证据更新,对心肌病的诊治及管理给出最新推荐。本文对该指南的重要推荐逐一进行解读,以便为医务工作者更好地理解和遵循指南提供帮助。.
{"title":"[Interpretation of the 2023 European Society of Cardiology (ESC) Guidelines for the management of cardiomyopathies].","authors":"X H Zheng, M Jiang, X L Li","doi":"10.3760/cma.j.cn112148-20230906-00131","DOIUrl":"10.3760/cma.j.cn112148-20230906-00131","url":null,"abstract":"随着近年来心肌病的相关循证医学证据及临床实践经验不断积累,欧洲心脏病学会于2023年公布了心肌病指南的更新,该指南结合整理了近年来领域内的证据更新,对心肌病的诊治及管理给出最新推荐。本文对该指南的重要推荐逐一进行解读,以便为医务工作者更好地理解和遵循指南提供帮助。.","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 11","pages":"1199-1204"},"PeriodicalIF":0.0,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107592361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Efficacy and feasibility of catheter-based adrenal ablation on Cushing's syndrome associated hypertension]. 导管肾上腺消融治疗库欣综合征相关性高血压的疗效和可行性。
Q3 Medicine Pub Date : 2023-11-24 DOI: 10.3760/cma.j.cn112148-20230801-00045
Z C Yan, N Jiang, H X Zhang, Q Zhou, X L Liu, F Sun, R M Yang, H B He, Z G Zhao, Z M Zhu

Objective: To explore the value of catheter-based adrenal ablation in treating Cushing's syndrome (CS)-associated hypertension. Methods: A clinical study was conducted in patients with CS, who received catheter-based adrenal ablation between March 2018 and July 2023 in Daping Hospital. Parameters monitored were blood pressure (outpatient and 24-hour ambulatory), body weight, clinical characteristics, serum cortisol and adrenocorticotropic hormone (ACTH) at 8 am, 24-hour urinary free cortisol (24 h UFC), fasting blood glucose and postoperative complications. Procedure effectiveness was defined as blood pressure returning to normal levels (systolic blood pressure<140 mmHg (1 mmHg=0.133 kPa) and diastolic blood pressure<90 mmHg), cortisol and 24 h UFC returning to normal and improvement of clinical characteristics. The parameters were monitored during follow up in the outpatient department at 1, 3, 6, and 12 months after catheter-based adrenal ablation. Results: A total of 12 patients (aged (40.0±13.2) years) were reviewed. There were 5 males, with 5 cases of adenoma and 7 with hyperplasia from imaging studies. Catheter-based adrenal ablation was successful in all without interruption or surgical conversion. No postoperative complication including bleeding, puncture site infection, adrenal artery rupture or adrenal bleeding was observed. The mean follow up was 28 months. Compared to baseline values, body weight declined to (59.48±11.65) kg from (64.81±10.75) kg (P=0.008), fasting blood glucose declined to (4.54±0.83) mmol from (5.53±0.99) mmol (P=0.044), outpatient systolic blood pressure declined to (128±21) mmHg from (140±19) mmHg (P=0.005), diastolic blood pressure declined to (78±10) mmHg from (86±11) mmHg (P=0.041), and the mean ambulatory daytime diastolic blood pressure declined to (79±12) mmHg from (89±8) mmHg (P=0.034). Catheter-based adrenal ablation in 8 patients was defined as effective with their 24 h UFC significantly reduced after the procedure (1 338.41±448.06) mmol/L from (633.66±315.94) mmol/L, P=0.011). The change of 24 h UFC between the effective treatment group and ineffective group was statistically significant (P=0.020). The postoperative systolic blood pressure in the treated adenoma group was significantly lower than those of hyperplasia group (112±13) mmHg vs. (139±20) mmHg, P=0.026). Conclusions: For patients with CS-associated hypertension who are unwilling or unable to undergo surgical treatment, catheter-based adrenal ablation could improve the blood pressure and cortisol level. Catheter-based adrenal ablation could be a safe, effective, and minimally invasive therapy. However, our results still need to be validated in further large-scale studies.

目的:探讨导管肾上腺消融治疗库欣综合征(CS)相关性高血压的价值。方法:对2018年3月至2023年7月在大坪医院行导管肾上腺消融术的CS患者进行临床研究。监测的参数包括血压(门诊和24小时门诊)、体重、临床特征、上午8点血清皮质醇和促肾上腺皮质激素(ACTH)、24小时尿游离皮质醇(24小时UFC)、空腹血糖和术后并发症。手术的有效性定义为血压恢复到正常水平(收缩压)。结果:共回顾了12例患者(年龄(40.0±13.2)岁)。男性5例,影像学检查腺瘤5例,增生7例。导管为基础的肾上腺消融均成功,无中断或手术转换。术后无出血、穿刺部位感染、肾上腺动脉破裂、肾上腺出血等并发症。平均随访时间为28个月。与基线值相比,体重从(64.81±10.75)kg降至(59.48±11.65)kg (P=0.008),空腹血糖从(5.53±0.99)mmol降至(4.54±0.83)mmol (P=0.044),门诊收缩压从(140±19)mmHg降至(128±21)mmHg (P=0.005),舒张压从(86±11)mmHg降至(78±10)mmHg (P=0.041),平均日间动态舒张压从(89±8)mmHg降至(79±12)mmHg (P=0.034)。8例患者经导管肾上腺消融后24小时UFC从(633.66±315.94)mmol/L显著降低(1 338.41±448.06)mmol/L, P=0.011,被定义为有效。有效组与无效组24 h UFC差异有统计学意义(P=0.020)。腺瘤治疗组术后收缩压明显低于增生组(112±13)mmHg vs(139±20)mmHg, P=0.026)。结论:对于不愿或不能接受手术治疗的cs相关性高血压患者,导管肾上腺消融可改善血压和皮质醇水平。导管肾上腺消融是一种安全、有效、微创的治疗方法。然而,我们的结果仍需要在进一步的大规模研究中得到验证。
{"title":"[Efficacy and feasibility of catheter-based adrenal ablation on Cushing's syndrome associated hypertension].","authors":"Z C Yan, N Jiang, H X Zhang, Q Zhou, X L Liu, F Sun, R M Yang, H B He, Z G Zhao, Z M Zhu","doi":"10.3760/cma.j.cn112148-20230801-00045","DOIUrl":"10.3760/cma.j.cn112148-20230801-00045","url":null,"abstract":"<p><p><b>Objective:</b> To explore the value of catheter-based adrenal ablation in treating Cushing's syndrome (CS)-associated hypertension. <b>Methods:</b> A clinical study was conducted in patients with CS, who received catheter-based adrenal ablation between March 2018 and July 2023 in Daping Hospital. Parameters monitored were blood pressure (outpatient and 24-hour ambulatory), body weight, clinical characteristics, serum cortisol and adrenocorticotropic hormone (ACTH) at 8 am, 24-hour urinary free cortisol (24 h UFC), fasting blood glucose and postoperative complications. Procedure effectiveness was defined as blood pressure returning to normal levels (systolic blood pressure<140 mmHg (1 mmHg=0.133 kPa) and diastolic blood pressure<90 mmHg), cortisol and 24 h UFC returning to normal and improvement of clinical characteristics. The parameters were monitored during follow up in the outpatient department at 1, 3, 6, and 12 months after catheter-based adrenal ablation. <b>Results:</b> A total of 12 patients (aged (40.0±13.2) years) were reviewed. There were 5 males, with 5 cases of adenoma and 7 with hyperplasia from imaging studies. Catheter-based adrenal ablation was successful in all without interruption or surgical conversion. No postoperative complication including bleeding, puncture site infection, adrenal artery rupture or adrenal bleeding was observed. The mean follow up was 28 months. Compared to baseline values, body weight declined to (59.48±11.65) kg from (64.81±10.75) kg (<i>P=</i>0.008), fasting blood glucose declined to (4.54±0.83) mmol from (5.53±0.99) mmol (<i>P=</i>0.044), outpatient systolic blood pressure declined to (128±21) mmHg from (140±19) mmHg (<i>P=</i>0.005), diastolic blood pressure declined to (78±10) mmHg from (86±11) mmHg (<i>P=</i>0.041), and the mean ambulatory daytime diastolic blood pressure declined to (79±12) mmHg from (89±8) mmHg (<i>P=</i>0.034). Catheter-based adrenal ablation in 8 patients was defined as effective with their 24 h UFC significantly reduced after the procedure (1 338.41±448.06) mmol/L from (633.66±315.94) mmol/L, <i>P=</i>0.011). The change of 24 h UFC between the effective treatment group and ineffective group was statistically significant (<i>P</i>=0.020). The postoperative systolic blood pressure in the treated adenoma group was significantly lower than those of hyperplasia group (112±13) mmHg vs. (139±20) mmHg, <i>P</i>=0.026). <b>Conclusions:</b> For patients with CS-associated hypertension who are unwilling or unable to undergo surgical treatment, catheter-based adrenal ablation could improve the blood pressure and cortisol level. Catheter-based adrenal ablation could be a safe, effective, and minimally invasive therapy. However, our results still need to be validated in further large-scale studies.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 11","pages":"1152-1159"},"PeriodicalIF":0.0,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107592359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Association between obstructive sleep apnea and vascular injury in hypertensive patients]. [高血压患者阻塞性睡眠呼吸暂停与血管损伤的关系]。
Q3 Medicine Pub Date : 2023-11-24 DOI: 10.3760/cma.j.cn112148-20230721-00015
N Yang, H D Chou, M T Wei, L L Shi, J J Duan, S Q Yin, Y M Li

Objective: To investigate the relationship between obstructive sleep apnea (OSA), apnea hypopnea index (AHI) and vascular injury in hypertensive patients. Methods: This cross-sectional study enrolled patients admitted to the Hypertension Department of TEDA International Cardiovascular Hospital from April 2020 to April 2023, who finished portable sleep monitoring. Sleep monitoring indicators, flow-mediated vasodilation (FMD), carotid artery ultrasound, carotid intima-media thickness, cervical and femoral pulse wave conduction velocity (cfPWV), brachial and ankle pulse wave conduction velocity (baPWV) were analyzed. OSA was classified into mild (5 times/h≤AHI<15 times/h), moderate (15≤AHI<30 times/h), and severe (AHI≥30 times/h) based on AHI levels. FMD<6.0% was defined as vascular endothelial injury, and cfPWV>10 m/s and/or baPWV>18 m/s was defined as arterial stiffness. Multivariate logistic regression analysis was used to explore the correlation between AHI, OSA severity and vascular injury, and subgroup analysis was performed in young (age≤45 years) and middle-to-old patients (age>45 years). Sensitivity analysis was performed by excluding patients with diabetes, cerebrovascular disease and coronary heart disease. The correlation between AHI and vascular injury index was analyzed by restricted cubic spline. Results: A total of 555 adult hypertensive patients were included, the mean age was (39.7±9.2) years, 422 were males (76.0%), and the prevalence of OSA was 66.7% (370/555). Multivariate logistic regression analysis showed that moderate OSA (OR=2.83, P=0.019) and severe OSA (OR=3.40, P=0.016) were positively correlated with vascular endothelial injury after adjusting for age, sex, body mass index and mean arterial pressure. Subgroup analysis showed that log AHI (OR=1.99, P=0.035), moderate OSA (OR=4.83, P=0.010) and severe OSA (OR=4.64, P=0.015) were associated with vascular endothelial injury in young hypertensive patients. The results of sensitivity analysis were similar to the above results. The results of restricted cubic spline analysis showed that AHI was correlated with FMD (P=0.022), and the slope of the curve was the largest when AHI was between 0 and 10 times/h. There was no correlation between log AHI and OSA severity and carotid intima-media thickening and arterial stiffness (all P<0.05). Conclusions: OSA is associated with vascular endothelial injury in hypertensive patients, especially in young patients.

目的:探讨高血压患者阻塞性睡眠呼吸暂停(OSA)、呼吸暂停低通气指数(AHI)与血管损伤的关系。方法:本横断面研究纳入2020年4月至2023年4月泰达国际心血管医院高血压科住院的患者,并完成便携式睡眠监测。分析睡眠监测指标、血流介导的血管舒张(FMD)、颈动脉超声、颈动脉内膜-中膜厚度、颈、股脉波传导速度(cfPWV)、肱、踝脉波传导速度(baPWV)。OSA分为轻度(5次/h≤AHI10 m/s和/或baPWV, >18 m/s定义为动脉僵硬)。采用多因素logistic回归分析探讨AHI、OSA严重程度与血管损伤的相关性,并对年轻(年龄≤45岁)和中老年(年龄≤45岁)患者进行亚组分析。通过排除糖尿病、脑血管疾病和冠心病患者进行敏感性分析。采用受限三次样条分析AHI与血管损伤指数的相关性。结果:共纳入成人高血压患者555例,平均年龄(39.7±9.2)岁,男性422例(76.0%),OSA患病率为66.7%(370/555)。多因素logistic回归分析显示,调整年龄、性别、体重指数、平均动脉压等因素后,中度OSA (OR=2.83, P=0.019)、重度OSA (OR=3.40, P=0.016)与血管内皮损伤呈正相关。亚组分析显示,青年高血压患者的log AHI (OR=1.99, P=0.035)、中度OSA (OR=4.83, P=0.010)、重度OSA (OR=4.64, P=0.015)与血管内皮损伤相关。敏感性分析结果与上述结果相似。限制三次样条分析结果显示AHI与FMD相关(P=0.022),且AHI在0 ~ 10次/h时曲线斜率最大。log AHI与OSA严重程度、颈动脉内膜-中膜增厚和动脉僵硬度无相关性(均p)。结论:OSA与高血压患者,尤其是年轻患者血管内皮损伤相关。
{"title":"[Association between obstructive sleep apnea and vascular injury in hypertensive patients].","authors":"N Yang, H D Chou, M T Wei, L L Shi, J J Duan, S Q Yin, Y M Li","doi":"10.3760/cma.j.cn112148-20230721-00015","DOIUrl":"10.3760/cma.j.cn112148-20230721-00015","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the relationship between obstructive sleep apnea (OSA), apnea hypopnea index (AHI) and vascular injury in hypertensive patients. <b>Methods:</b> This cross-sectional study enrolled patients admitted to the Hypertension Department of TEDA International Cardiovascular Hospital from April 2020 to April 2023, who finished portable sleep monitoring. Sleep monitoring indicators, flow-mediated vasodilation (FMD), carotid artery ultrasound, carotid intima-media thickness, cervical and femoral pulse wave conduction velocity (cfPWV), brachial and ankle pulse wave conduction velocity (baPWV) were analyzed. OSA was classified into mild (5 times/h≤AHI<15 times/h), moderate (15≤AHI<30 times/h), and severe (AHI≥30 times/h) based on AHI levels. FMD<6.0% was defined as vascular endothelial injury, and cfPWV>10 m/s and/or baPWV>18 m/s was defined as arterial stiffness. Multivariate logistic regression analysis was used to explore the correlation between AHI, OSA severity and vascular injury, and subgroup analysis was performed in young (age≤45 years) and middle-to-old patients (age>45 years). Sensitivity analysis was performed by excluding patients with diabetes, cerebrovascular disease and coronary heart disease. The correlation between AHI and vascular injury index was analyzed by restricted cubic spline. <b>Results:</b> A total of 555 adult hypertensive patients were included, the mean age was (39.7±9.2) years, 422 were males (76.0%), and the prevalence of OSA was 66.7% (370/555). Multivariate logistic regression analysis showed that moderate OSA (<i>OR</i>=2.83, <i>P</i>=0.019) and severe OSA (<i>OR</i>=3.40, <i>P</i>=0.016) were positively correlated with vascular endothelial injury after adjusting for age, sex, body mass index and mean arterial pressure. Subgroup analysis showed that log AHI (<i>OR</i>=1.99, <i>P</i>=0.035), moderate OSA (<i>OR</i>=4.83, <i>P</i>=0.010) and severe OSA (<i>OR</i>=4.64, <i>P</i>=0.015) were associated with vascular endothelial injury in young hypertensive patients. The results of sensitivity analysis were similar to the above results. The results of restricted cubic spline analysis showed that AHI was correlated with FMD (<i>P</i>=0.022), and the slope of the curve was the largest when AHI was between 0 and 10 times/h. There was no correlation between log AHI and OSA severity and carotid intima-media thickening and arterial stiffness (all <i>P</i><0.05). <b>Conclusions:</b> OSA is associated with vascular endothelial injury in hypertensive patients, especially in young patients.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 11","pages":"1137-1144"},"PeriodicalIF":0.0,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107592438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The clinical application of the index of microcirculatory resistance in patients with STEMI]. [微循环耐药指标在STEMI患者中的临床应用]。
Q3 Medicine Pub Date : 2023-11-24 DOI: 10.3760/cma.j.cn112148-20230915-00164
Y B Long, C C Huang, H W Pan, J J Rong
经皮冠状动脉介入治疗是急性ST段抬高型心肌梗死的首选治疗策略,可有效恢复病变血管血供从而降低死亡率,但部分患者术后无法达到有效再灌注,这主要与冠状动脉微循环障碍有关。微循环阻力指数(IMR)是反映冠状动脉微循环障碍最有效的指标,已有多种IMR的测量方法应用于临床并显示出良好的应用前景。目前,有多种药物被证明具有降低IMR的作用。本文将总结IMR最新研究进展,以期为临床提供指导。.
{"title":"[The clinical application of the index of microcirculatory resistance in patients with STEMI].","authors":"Y B Long, C C Huang, H W Pan, J J Rong","doi":"10.3760/cma.j.cn112148-20230915-00164","DOIUrl":"10.3760/cma.j.cn112148-20230915-00164","url":null,"abstract":"经皮冠状动脉介入治疗是急性ST段抬高型心肌梗死的首选治疗策略,可有效恢复病变血管血供从而降低死亡率,但部分患者术后无法达到有效再灌注,这主要与冠状动脉微循环障碍有关。微循环阻力指数(IMR)是反映冠状动脉微循环障碍最有效的指标,已有多种IMR的测量方法应用于临床并显示出良好的应用前景。目前,有多种药物被证明具有降低IMR的作用。本文将总结IMR最新研究进展,以期为临床提供指导。.","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 11","pages":"1130-1136"},"PeriodicalIF":0.0,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107592366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Differential expression and implication of m6A methylation in mice with experimental myocardial infarction]. [m6A甲基化在实验性心肌梗死小鼠中的差异表达及其意义]。
Q3 Medicine Pub Date : 2023-11-24 DOI: 10.3760/cma.j.cn112148-20230918-00171
S C Zhang, X Y Zhao, L L Chen, X Zhou

Objective: To define differentially expressed N6-adenylate methylation (m6A) genes in the myocardial tissue of mice with myocardial infarction (MI) and explore its potential impact on the pathological process of MI. Methods: The random number table method was used to divide the eighteen SPF C57BL/6J male mice aged from 8 to 10 weeks into MI group (MI group, n=9) and control group (control group, n=9). Modified m6A genes from the myocardial tissue were detected via methylated RNA immunoprecipitation with the next generation sequencing (MeRIP-seq). We explored methylation modified characteristics, verified mRNA expression and m6A modified level by bioinformatics analysis, qPCR and MeRIP-qPCR. Results: The Heatmap revealed that 901 differentially modified m6A genes between MI and control group, of which 537 genes were upregulated, and 364 genes were downregulated. The principal component analysis affirmed that two groups could be distinguished significantly in terms of m6A gene modification. The characteristic sequence of m6A modification was GGACU and mainly concentrated in the coding sequence. According to the conjoint analysis with RNA-seq and MeRIP-seq, 119 genes expressed simultaneous m6A modification difference and mRNA expression difference. The Venn diagram exhibited the positive and negative correlation between m6A modification and mRNA expression. Besides, the GO enrichment analysis indicated that the genes with m6A differential modification in MI group were mainly involved in heart development and other processes. qPCR verified that Gbp6 was up-regulated, while Dnaja1 and Dnajb1 were down-regulated. MeRIP-qPCR revealed that the m6A modification level of Hspa1b was downregulated. Conclusion: Myocardial infarction induces differential modification of m6A in the mice model. In addition, the genes with m6A modification may be affected by methylation related enzymes, thus participating the pathogenesis of MI by regulating apoptosis and inflammation.

目的:明确n6 -腺苷酸甲基化(m6A)基因在心肌梗死(MI)小鼠心肌组织中的差异表达,并探讨其对MI病理过程的潜在影响。方法:采用随机数字表法将8 ~ 10周龄SPF C57BL/6J雄性小鼠18只分为MI组(MI组,n=9)和对照组(对照组,n=9)。通过甲基化RNA免疫沉淀和下一代测序(MeRIP-seq)检测心肌组织中修饰的m6A基因。通过生物信息学分析、qPCR和MeRIP-qPCR,探讨甲基化修饰特征,验证mRNA表达和m6A修饰水平。结果:热图显示心肌梗死组与对照组存在901个m6A基因的差异修饰,其中537个基因表达上调,364个基因表达下调。主成分分析证实两组在m6A基因修饰方面具有显著性差异。m6A修饰的特征序列为GGACU,主要集中在编码序列中。结合RNA-seq和MeRIP-seq分析,119个基因同时表达m6A修饰差异和mRNA表达差异。维恩图显示m6A修饰与mRNA表达呈正相关和负相关。此外,GO富集分析表明,MI组m6A差异修饰基因主要参与心脏发育等过程。qPCR证实Gbp6上调,Dnaja1和Dnajb1下调。MeRIP-qPCR结果显示Hspa1b的m6A修饰水平下调。结论:心肌梗死引起小鼠模型m6A的差异修饰。此外,m6A修饰的基因可能受到甲基化相关酶的影响,从而通过调节细胞凋亡和炎症参与心肌梗死的发病。
{"title":"[Differential expression and implication of m6A methylation in mice with experimental myocardial infarction].","authors":"S C Zhang, X Y Zhao, L L Chen, X Zhou","doi":"10.3760/cma.j.cn112148-20230918-00171","DOIUrl":"10.3760/cma.j.cn112148-20230918-00171","url":null,"abstract":"<p><p><b>Objective:</b> To define differentially expressed N6-adenylate methylation (m6A) genes in the myocardial tissue of mice with myocardial infarction (MI) and explore its potential impact on the pathological process of MI. <b>Methods:</b> The random number table method was used to divide the eighteen SPF C57BL/6J male mice aged from 8 to 10 weeks into MI group (MI group, <i>n</i>=9) and control group (control group, <i>n</i>=9). Modified m6A genes from the myocardial tissue were detected via methylated RNA immunoprecipitation with the next generation sequencing (MeRIP-seq). We explored methylation modified characteristics, verified mRNA expression and m6A modified level by bioinformatics analysis, qPCR and MeRIP-qPCR. <b>Results:</b> The Heatmap revealed that 901 differentially modified m6A genes between MI and control group, of which 537 genes were upregulated, and 364 genes were downregulated. The principal component analysis affirmed that two groups could be distinguished significantly in terms of m6A gene modification. The characteristic sequence of m6A modification was GGACU and mainly concentrated in the coding sequence. According to the conjoint analysis with RNA-seq and MeRIP-seq, 119 genes expressed simultaneous m6A modification difference and mRNA expression difference. The Venn diagram exhibited the positive and negative correlation between m6A modification and mRNA expression. Besides, the GO enrichment analysis indicated that the genes with m6A differential modification in MI group were mainly involved in heart development and other processes. qPCR verified that Gbp6 was up-regulated, while Dnaja1 and Dnajb1 were down-regulated. MeRIP-qPCR revealed that the m6A modification level of Hspa1b was downregulated. <b>Conclusion:</b> Myocardial infarction induces differential modification of m6A in the mice model. In addition, the genes with m6A modification may be affected by methylation related enzymes, thus participating the pathogenesis of MI by regulating apoptosis and inflammation.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 11","pages":"1166-1174"},"PeriodicalIF":0.0,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"107592358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华心血管病杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1